Conduction System Pacing versus Conventional Biventricular Pacing for Cardiac Resynchronization Therapy: Where Are We
Giulia Domenichini1, Mathieu Le Bloa1, Cheryl Teres Castillo1
1Cardiology Service, University Hospital of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland.
Conduction system pacing (CSP) offers physiological ventricular activation for heart failure patients needing cardiac resynchronization therapy (CRT). While promising, further large studies are needed to confirm its long-term efficacy and lead performance for routine clinical use.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Conduction system pacing (CSP) is a novel pacing strategy offering physiological ventricular activation, surpassing conventional right ventricular pacing for bradycardia.
- CSP is emerging as an alternative to biventricular pacing for cardiac resynchronization therapy (CRT) in heart failure patients.
- Current clinical data suggest CSP's potential for CRT, but large randomized trials are lacking to establish its routine use.
Purpose of the Study:
- To review the current state-of-the-art of conduction system pacing (CSP) as an alternative to biventricular pacing for CRT in heart failure.
- To discuss the physiological principles underpinning CSP for CRT.
- To explore future perspectives of CSP in CRT, considering implant techniques and available clinical data.
Main Methods:
- Review of existing literature on conduction system pacing (CSP) for cardiac resynchronization therapy (CRT).
- Analysis of physiological concepts supporting CSP in heart failure.
- Discussion of implant techniques including His bundle pacing and left bundle branch area pacing.
- Evaluation of published clinical data regarding CSP for CRT.
Main Results:
- CSP provides a more physiological ventricular activation compared to conventional pacing methods.
- Preliminary data suggest CSP is a viable alternative for CRT, though long-term outcomes require further investigation.
- Concerns regarding long-term lead performance and extractability for CSP need to be addressed.
Conclusions:
- Conduction system pacing (CSP) presents a promising physiological approach for cardiac resynchronization therapy (CRT) in heart failure patients.
- Further robust clinical evidence from large randomized trials is essential to validate CSP's efficacy and safety for widespread adoption.
- Ongoing research into implant techniques and lead technology will shape the future of CSP in CRT.
Related Concept Videos
Conduction System of the Heart
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
Electrophysiology of Normal Cardiac Rhythm
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Cardiopulmonary Resuscitation IV: Pharmacological Management


